Diurnal rhythms are altered in a mouse model of multiple sclerosis

Journal of Neuroimmunology

Volumn 243, Issue 1-2, 2012, Pages 12-17

  Buenafe, Abigail C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Circadian regulation; Clock genes; Corticosterone; Diurnal rhythm; Experimental autoimmune encephalomyelitis; Multiple sclerosis

Indexed keywords

BETA ACTIN; CORTICOSTERONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LEPTIN; PER2 PROTEIN; TRANSCRIPTION FACTOR CLOCK;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD PRESSURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GENETIC VARIABILITY; HEART RATE; HORMONE BLOOD LEVEL; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANIMALS; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; CLOCK PROTEINS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PERIOD CIRCADIAN PROTEINS; PERTUSSIS TOXIN; T-LYMPHOCYTES; TIME FACTORS;

EID: 84856948434     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.12.002     Document Type: Article

References (56)

1. Ando H., Ushijima K., Yanagihara H., Hayashi Y., Takamura T., Kaneko S., Fujimura A. Clock gene expression in the liver and adipose tissues of non-obese type 2 diabetic Goto-Kakizaki rats. Clin. Exp. Hypertens. (New York) 2009, 31:201-207.
2. Arjona A., Sarkar D.K. Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J. Immunol. 2005, 174:7618-7624.
3. Arvidson N.G., Gudbjornsson B., Larsson A., Hallgren R. The timing of glucocorticoid administration in rheumatoid arthritis. Ann. Rheum. Dis. 1997, 56:27-31.
4. Attarian H.P., Brown K.M., Duntley S.P., Carter J.D., Cross A.H. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch. Neurol. 2004, 61:525-528.
5. Balsalobre A., Brown S.A., Marcacci L., Tronche F., Kellendonk C., Reichardt H.M., Schutz G., Schibler U. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 2000, 289:2344-2347.
6. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 2003, 197:1073-1081.
7. Bolton C., O'Neill J.K., Allen S.J., Baker D. Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids. Int. Arch. Allergy Immunol. 1997, 114:74-80.
8. Buenafe A.C., Bourdette D.N. Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007, 182:32-40.
9. Buenafe A.C., Zwickey H., Moes N., Oken B., Jones R.E. A telemetric study of physiologic changes in mice with induced autoimmune encephalomyelitis. Lab Anim. 2008, 37:361-368.
10. Buttgereit F., Doering G., Schaeffler A., Witte S., Sierakowski S., Gromnica-Ihle E., Jeka S., Krueger K., Szechinski J., Alten R. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69:1275-1280.
11. Cutolo M., Straub R.H. Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmun. Rev. 2008, 7:223-228.
12. Cutolo M., Villaggio B., Otsa K., Aakre O., Sulli A., Seriolo B. Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. Autoimmun. Rev. 2005, 4:497-502.
13. Cutolo M., Sulli A., Pizzorni C., Secchi M.E., Soldano S., Seriolo B., Straub R.H., Otsa K., Maestroni G.J. Circadian rhythms: glucocorticoids and arthritis. Ann. N. Y. Acad. Sci. 2006, 1069:289-299.
14. Damiola F., Le Minh N., Preitner N., Kornmann B., Fleury-Olela F., Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000, 14:2950-2961.
15. De Rosa V., Procaccini C., Cali G., Pirozzi G., Fontana S., Zappacosta S., La Cava A., Matarese G. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007, 26:241-255.
16. del Rey A., Klusman I., Besedovsky H.O. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1. Am. J. Physiol. 1998, 275:R1146-R1151.
17. Dickmeis T. Glucocorticoids and the circadian clock. J. Endocrinol. 2009, 200:3-22.
18. Edwards S., Lennox G., Robson K., Whiteley A. Hypothermia due to hypothalamic involvement in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1996, 61:419-420.
19. Gery S., Koeffler H.P. The role of circadian regulation in cancer. Cold Spring Harb. Symp. Quant. Biol. 2007, 72:459-464.
20. Glass-Marmor L., Paperna T., Galboiz Y., Miller A. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J. Neuroimmunol. 2009, 210:124-127.
21. Gooley J.J., Lu J., Chou T.C., Scammell T.E., Saper C.B. Melanopsin in cells of origin of the retinohypothalamic tract. Nat. Neurosci. 2001, 4:1165.
22. Gottschalk M., Kumpfel T., Flachenecker P., Uhr M., Trenkwalder C., Holsboer F., Weber F. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch. Neurol. 2005, 62:277-280.
23. Guo H., Brewer J.M., Lehman M.N., Bittman E.L. Suprachiasmatic regulation of circadian rhythms of gene expression in hamster peripheral organs: effects of transplanting the pacemaker. J. Neurosci. 2006, 26:6406-6412.
24. Hasenkrug K.J. The leptin connection: regulatory T cells and autoimmunity. Immunity 2007, 26:143-145.
25. Huitinga I., De Groot C.J., Van der Valk P., Kamphorst W., Tilders F.J., Swaab D.F. Hypothalamic lesions in multiple sclerosis. J. Neuropathol. Exp. Neurol. 2001, 60:1208-1218.
26. Huitinga I., Erkut Z.A., van Beurden D., Swaab D.F. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann. Neurol. 2004, 55:37-45.
27. Kalsbeek A., Fliers E., Romijn J.A., La Fleur S.E., Wortel J., Bakker O., Endert E., Buijs R.M. The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology 2001, 142:2677-2685.
28. Kuchroo V.K., Nicholson L.B. Fast and feel good?. Nature 2003, 422:27-28.
29. Lahti T.A., Partonen T., Kyyronen P., Kauppinen T., Pukkala E. Night-time work predisposes to non-Hodgkin lymphoma. Int. J. Cancer 2008, 123:2148-2151.
30. Levi F., Filipski E., Iurisci I., Li X.M., Innominato P. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics. Cold Spring Harb. Symp. Quant. Biol. 2007, 72:465-475.
31. MacPhee I.A., Antoni F.A., Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 1989, 169:431-445.
32. Magri F., Cravello L., Barili L., Sarra S., Cinchetti W., Salmoiraghi F., Micale G., Ferrari E. Stress and dementia: the role of the hypothalamicpituitary-adrenal axis. Aging Clin. Exp. Res. 2006, 18:167-170.
33. Marcheva B., Ramsey K.M., Affinati A., Bass J. Clock genes and metabolic disease. J. Appl. Physiol. 2009, 107:1638-1646.
34. Martinez-Rodriguez J.E., Munteis E., Roquer J. Periodic hyperthermia and abnormal circadian temperature rhythm in a patient with multiple sclerosis. Mult. Scler. 2006, 12:515-517.
35. Maywood E.S., O'Brien J.A., Hastings M.H. Expression of mCLOCK and other circadian clock-relevant proteins in the mouse suprachiasmatic nuclei. J. Neuroendocrinol. 2003, 15:329-334.
36. Okamura H. Clock genes in cell clocks: roles, actions, and mysteries. J. Biol. Rhythm. 2004, 19:388-399.
37. Prasai M.J., George J.T., Scott E.M. Molecular clocks, type 2 diabetes and cardiovascular disease. Diab. Vasc. Dis. Res. 2008, 5:89-95.
38. Rasmussen L.E., Buss I.O., Hess D.L., Schmidt M.J. Testosterone and dihydrotestosterone concentrations in elephant serum and temporal gland secretions. Biol. Reprod. 1984, 30:352-362.
39. Rudic R.D., McNamara P., Curtis A.-M., Boston R.C., Panda S., Hogenesch J.B., Fitzgerald G.A. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol. 2004, 2:e377.
40. Sanna V., Di Giacomo A., La Cava A., Lechler R.I., Fontana S., Zappacosta S., Matarese G. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 2003, 111:241-250.
41. Shaw E., Tofler G.H. Circadian rhythm and cardiovascular disease. Curr. Atheroscler. Rep. 2009, 11:289-295.
42. Shindler K.S., Ventura E., Dutt M., Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp. Eye Res. 2008, 87:208-213.
43. So A.Y.L., Bernal T.U., Pillsbury M.L., Yamamoto K.R., Feldman B.J. Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17582-17587.
44. Son G.H., Chung S., Choe H.K., Kim H.-D., Baik S.-M., Lee H., Lee H.-W., Choi S., Sun W., Kim H., Cho S., Lee K.H., Kim K. Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:20970-20975.
45. Stefferl A., Storch M.K., Linington C., Stadelmann C., Lassmann H., Pohl T., Holsboer F., Tilders F.J., Reul J.M. Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. Endocrinology 2001, 142:3616-3624.
46. Stokkan K.A., Yamazaki S., Tei H., Sakaki Y., Menaker M. Entrainment of the circadian clock in the liver by feeding. Science 2001, 291:490-493.
47. Tsujino T., Naito Y., Kawasaki D., Okuda S., Sakoda T., Fujioka Y., Sugaya T., Ohyanagi M. Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice. Clin. Exp. Hypertens. (New York) 2005, 27:159-168.
48. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Losee-Olson S., Easton A., Jensen D.R., Eckel R.H., Takahashi J.S., Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005, 308:1043-1045.
49. van der Veen D.R., Minh N.L., Gos P., Arneric M., Gerkema M.P., Schibler U. Impact of behavior on central and peripheral circadian clocks in the common vole Microtus arvalis, a mammal with ultradian rhythms. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3393-3398.
50. Walker B.R. Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 2007, 157:545-559.
51. Weiss N., Hasboun D., Demeret S., Fontaine B., Bolgert F., Lyon-Caen O., Chabas D. Paroxysmal hypothermia as a clinical feature of multiple sclerosis. Neurology 2009, 72:193-195.
52. White K.D., Scoones D.J., Newman P.K. Hypothermia in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1996, 61:369-375.
53. Wu Y.-H., Swaab D.F. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med. 2007, 8:623-636.
54. Yamamoto T., Nakahata Y., Soma H., Akashi M., Mamine T., Takumi T. Transcriptional oscillation of canonical clock genes in mouse peripheral tissues. BMC Mol. Biol. 2004, 5:18-26.
55. Yoo S.-H., Yamazaki S., Lowrey P.L., Shimomura K., Ko C.H., Buhr E.D., Siepka S.M., Hong H.-K., Oh W.J., Yoo O.J., Menaker M., Takahashi J.S. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5339-5346.
56. Zvonic S., Ptitsyn A.A., Conrad S.A., Scott L.K., Floyd Z.E., Kilroy G., Wu X., Goh B.C., Mynatt R.L., Gimble J.M. Characterization of peripheral circadian clocks in adipose tissues. Diabetes 2006, 55:962-970.